Browse the latest research summaries in the field of biomedical for spinal cord injury patients and caregivers.
Showing 621-630 of 904 results
Advanced Science, 2024 • November 30, 2023
This study introduces a novel strategy for treating spinal cord injury (SCI) by targeting the recovery of mitochondrial energy metabolism through a combination of ROS scavenging and energy supplementa...
KEY FINDING: Ligand-screened cerium-based MOFs with creatine loading and polydopamine encapsulation (Gel-Cr/Ce@PDA) regulate macrophage phenotypes towards M2 via metabolic reprogramming.
Materials Today Bio, 2023 • November 10, 2023
This study introduces a novel biomimetic nanoplatform, pCel, for treating spinal cord injury (SCI) by leveraging the anti-inflammatory and neuroprotective properties of celastrol. In vitro and in vivo...
KEY FINDING: The pCel nanoplatform exhibits high ROS scavenging activity and promotes the polarization of M1 macrophages toward the M2 phenotype in vitro.
Advanced Healthcare Materials, 2024 • December 16, 2023
This study presents a novel thermoresponsive hydrogel that encapsulates dental pulp stem cells (DPSCs) and delivers hydrogen sulfide (H2S) for spinal cord injury (SCI) repair. The hydrogel incorporate...
KEY FINDING: The PF-OMSF@JK composite hydrogel significantly improves in vivo SCI regeneration in Sprague–Dawley rats through a reduction in inflammation and neuronal differentiation of the incorporated stem cells.
International Journal of Nanomedicine, 2023 • December 5, 2023
The study synthesized a novel injectable hydrogel containing bFGF (HA-bFGF) and proved it had superior biocompatibility. HA-bFGF assisted with the regeneration of myelin sheath after an SCI. HA-bFGF c...
KEY FINDING: HA-bFGF hydrogel had no toxicity to the organs of rats and was relatively safe, indicating a higher level of biocompatibility.
International Journal of Nanomedicine, 2023 • December 6, 2023
Spinal cord injury (SCI) treatment remains a significant clinical challenge, but neural tissue engineering offers a promising therapeutic approach through the implantation of functionalized electrocon...
KEY FINDING: Glial fibrosis and fluid-filled cysts impede electrical signaling and stimulus conduction in spinal cord tissue, hindering neural regeneration.
Biomaterials, 2024 • March 1, 2024
This study presents the design of a delivery vehicle customized for transplantation of human cortical projection neurons into the injured cervical spinal cord, utilizing a family of SHIELD gels with d...
KEY FINDING: SHIELD with the RGDS ligand demonstrated the highest cell viability and the most robust neurite outgrowth in vitro.
Advanced Science, 2024 • December 25, 2023
The study developed LMGDNPs, injectable hydrogel microspheres, to address the nutrient imbalance and harsh microenvironment in degenerated intervertebral discs (IVD). LMGDNPs promoted cell survival an...
KEY FINDING: LMGDNPs showed a delayed release of lactate oxidase (LOX) and effectively consumed lactate, a harmful metabolic byproduct, creating a more favorable environment for cells.
ACS Nano, 2024 • January 18, 2024
The study introduces MnO2@TMNP, a novel nanomaterial designed to address disc degeneration and discogenic pain by targeting inflammation and promoting tissue regeneration. MnO2@TMNP's macrophage membr...
KEY FINDING: MnO2@TMNP effectively binds inflammatory factors and nerve growth factors, inhibiting inflammation-induced apoptosis and nerve ingrowth.
Nanoscale Advances, 2024 • January 1, 2024
This study designs and introduces a new GO-based nanomaterial to minimize inflammation and stimulate neurite regrowth. Preliminary biological investigations on bone marrow derived mesenchymal stem cell...
KEY FINDING: Graphene-based nanocarriers did not show cell toxicity and enhanced bone marrow derived mesenchymal stem cell (BM-MSC) proliferation by approximately 10% after 48 hours.
Journal of Nanobiotechnology, 2024 • February 9, 2024
The study investigates the therapeutic potential of hADSC-derived exosomes (hADSC-Exos) for autism spectrum disorder (ASD) by examining their effects on neurogenesis and ASD-like behaviors in BTBR mic...
KEY FINDING: hADSC-Exos promote neurogenesis in brain organoid and ameliorate social deficits in ASD mouse model BTBR T + tf/J (BTBR).